Fjarde AP Fonden Fourth Swedish National Pension Fund Increases Stake in Pfizer Inc. $PFE

Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its holdings in shares of Pfizer Inc. (NYSE:PFE) by 56.4% during the 1st quarter, Holdings Channel.com reports. The firm owned 1,441,271 shares of the biopharmaceutical company’s stock after buying an additional 519,500 shares during the quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in Pfizer were worth $40,471,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Horizon Financial Services LLC grew its stake in shares of Pfizer by 174.8% during the fourth quarter. Horizon Financial Services LLC now owns 1,014 shares of the biopharmaceutical company’s stock valued at $25,000 after buying an additional 645 shares during the last quarter. Godfrey Financial Associates Inc. bought a new stake in shares of Pfizer in the 4th quarter valued at about $26,000. YANKCOM Partnership purchased a new stake in Pfizer during the 4th quarter valued at about $28,000. HFM Investment Advisors LLC boosted its holdings in Pfizer by 61.0% during the 4th quarter. HFM Investment Advisors LLC now owns 1,127 shares of the biopharmaceutical company’s stock valued at $28,000 after acquiring an additional 427 shares during the period. Finally, Global Trust Asset Management LLC grew its position in Pfizer by 126.7% during the 1st quarter. Global Trust Asset Management LLC now owns 1,163 shares of the biopharmaceutical company’s stock worth $33,000 after acquiring an additional 650 shares during the last quarter. 68.36% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have weighed in on PFE shares. BMO Capital Markets reiterated an “outperform” rating on shares of Pfizer in a research report on Tuesday, June 23rd. Citigroup raised their target price on shares of Pfizer from $26.00 to $27.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. HSBC lifted their target price on shares of Pfizer from $29.00 to $32.00 and gave the stock a “buy” rating in a research note on Tuesday, March 17th. Wall Street Zen raised shares of Pfizer from a “hold” rating to a “buy” rating in a research report on Sunday, June 21st. Finally, UBS Group reissued a “neutral” rating and issued a $27.00 price target on shares of Pfizer in a report on Wednesday, May 27th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, twelve have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, Pfizer presently has an average rating of “Hold” and an average price target of $28.82.

Pfizer Trading Up 1.7%

NYSE PFE opened at $24.29 on Friday. The stock has a market cap of $138.45 billion, a P/E ratio of 18.54 and a beta of 0.35. Pfizer Inc. has a fifty-two week low of $23.11 and a fifty-two week high of $28.75. The stock has a 50 day simple moving average of $25.68 and a two-hundred day simple moving average of $26.24. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.94 and a current ratio of 1.25.

Pfizer (NYSE:PFE) last posted its earnings results on Tuesday, May 5th. The biopharmaceutical company reported $0.75 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.72 by $0.03. Pfizer had a return on equity of 19.44% and a net margin of 11.83%.The firm had revenue of $14.45 billion for the quarter, compared to analysts’ expectations of $13.84 billion. During the same period in the previous year, the firm earned $0.92 earnings per share. The business’s revenue was up 5.4% compared to the same quarter last year. Pfizer has set its FY 2026 guidance at 2.800-3.000 EPS. On average, analysts forecast that Pfizer Inc. will post 2.99 earnings per share for the current year.

Pfizer Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 1st. Shareholders of record on Friday, July 24th will be issued a $0.43 dividend. The ex-dividend date is Friday, July 24th. This represents a $1.72 annualized dividend and a yield of 7.1%. Pfizer’s dividend payout ratio is 131.30%.

Pfizer Profile

Pfizer Inc (NYSE: PFE) is a multinational biopharmaceutical company headquartered in New York City. Founded in 1849 by Charles Pfizer and Charles Erhart, the company researches, develops, manufactures and commercializes a broad range of medicines and vaccines for human health. Its activities span discovery research, clinical development, regulatory affairs, manufacturing and global commercial distribution across multiple therapeutic areas.

Pfizer’s portfolio and pipeline cover oncology, immunology, cardiology, endocrinology, rare diseases, hospital acute care and anti-infectives, along with a substantial vaccine business.